ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 826

Systemic Sclerosis Inpatient Mortality Has Not Improved from 1995-2011. Results from a National Irish Audit of Scleroderma Co-Morbidities.

Len Harty1, Deirdre Fitzgerald2, Michael Henry2, John Ryan3 and Sinead Harney3, 1Cork University Hospital, Cork, Ireland, 2Respiratory, Cork University Hospital, Cork, Ireland, 3Rheumatology, Cork University Hospital, Cork, Ireland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoimmune diseases, Co-morbidities, morbidity and mortality, scleroderma and scleroderma-like conditions

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Despite the advent of potent immunosuppressive and vasoactive therapies it is not clear that longevity of patients with systemic sclerosis (SSc) has improved. Therefore we sought to evaluate the age of death of SSc inpatients (inpts) relative to general inpts, the number of hospital inpt days and comorbidities in SSc patients.

Methods: The Hospital In-Patient Enquiry system was evaluated from 57 Irish hospitals from 1995-2011 for patients admitted with a diagnosis of SSc. Age, length of stay (LOS), gender and admitting indication were recorded. Results are shown as totals and mean (Standard deviation). Trends were examined by logistic regression analysis; Mann –Whitney  U was used to compare groups. p<0.05 was considered statistically significant. 

Results: 2667 inpt admissions occurred; 4:1, F:M, mean age 59yrs (15). On average 157 (15) admissions occurred annually for SSc patients, without variation (p=0.7). 146 patients died in hospital at average 65yrs (5) without annual improvement (r2=0.03, p=0.5). SSc age of death was younger than general inpts (p<0.0001), whose longevity improved from 72 to 74yrs (r2=0.9, p<0.0001). Male SSc inpts were average 6yrs younger than female at death (60yrs (10) v 66 yrs (6); p<0.01) in contrast to general inpts when men were average 3yrs younger than women at death (70 yrs v 73 yrs). SSc LOS increased from 11 to 14 days (r2=0.3, p=0.03), as did age of admission (r2=0.4, p<0.01). Autoimmune disease (predominantly scleroderma) was the commonest admitting diagnosis (n=945). Lung disease accounted for 383 admissions (170 infection, 62 PAH), CVS disease n=397 (236 limb / cardiac / cerebral ischaemic events, 51 heart failure, 32 arrhythmia), GI n=301, Rehab n= 151, MSK n=120, Haematological n=89 (52 anaemia), Renal n= 85 (51 Failure, 19 infection). 16 pregnancies were recorded with 2 spontaneous abortions, 3 pre-eclampsia incidents, and 9 unspecified complications. Imaging was the commonest principal procedure (n=346), followed by IV therapy (n=297), allied health professional intervention (n=277), gastroscopy (n=208) with 62 patients undergoing limb amputation and 9 having kidney transplants.

Conclusion:   Age of death among SSc inpts is not improving in contrast to unaffected inpts whose age of death is increasing, worse in men. SSc LOS is increasing in contrast to unaffected inpts whose LOS is decreasing. Cardiopulmonary comorbidity predominates among Irish SSc inpts supporting the need for more awareness and therapeutics to address this aspect of SSc.


Disclosure: L. Harty, None; D. Fitzgerald, None; M. Henry, None; J. Ryan, None; S. Harney, None.

To cite this abstract in AMA style:

Harty L, Fitzgerald D, Henry M, Ryan J, Harney S. Systemic Sclerosis Inpatient Mortality Has Not Improved from 1995-2011. Results from a National Irish Audit of Scleroderma Co-Morbidities. [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/systemic-sclerosis-inpatient-mortality-has-not-improved-from-1995-2011-results-from-a-national-irish-audit-of-scleroderma-co-morbidities/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-sclerosis-inpatient-mortality-has-not-improved-from-1995-2011-results-from-a-national-irish-audit-of-scleroderma-co-morbidities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology